Header Logo

Connection

DANIEL PENNY to Sulfonamides

Back to Details
This is a "connection" page, showing publications DANIEL PENNY has written about Sulfonamides.
DANIEL PENNY
Connection Strength
0.330
Sulfonamides
  1. The Fontan Udenafil Exercise Longitudinal Trial: Subgroup Analysis. Pediatr Cardiol. 2023 Dec; 44(8):1691-1701.
    View in: PubMed
    Score: 0.113
  2. Results of the FUEL Trial. Circulation. 2020 02 25; 141(8):641-651.
    View in: PubMed
    Score: 0.088
  3. Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial. Am Heart J. 2018 07; 201:1-8.
    View in: PubMed
    Score: 0.079
  4. Preliminary experience with bosentan as initial therapy in childhood idiopathic pulmonary arterial hypertension. J Heart Lung Transplant. 2006 Apr; 25(4):469-73.
    View in: PubMed
    Score: 0.034
  5. Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report. BMC Pulm Med. 2016 Jan 22; 16:17.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.